Preventing pathological regression of blood vessels.
Keshet
Eli
E
Department of Molecular Biology, The Hebrew University-Hadassah Medical School, Jerusalem, Israel. keshet@cc.huji.ac.il
D000818:Animals; D016228:Endothelial Growth Factors / Q000627:therapeutic use*; D006801:Humans; D007231:Infant, Newborn; D036341:Intercellular Signaling Peptides and Proteins / Q000627:therapeutic use*; D008222:Lymphokines / Q000627:therapeutic use*; D051379:Mice; D010100:Oxygen / Q000633:toxicity*; D000072483:Placenta Growth Factor; D011257:Pregnancy Proteins / Q000627:therapeutic use*; D012160:Retina / Q000473:pathology*; D012178:Retinopathy of Prematurity / Q000188:drug therapy* / Q000473:pathology; D042461:Vascular Endothelial Growth Factor A; D040281:Vascular Endothelial Growth Factor Receptor-1 / Q000502:physiology*; D042442:Vascular Endothelial Growth Factors
D016228:Endothelial Growth Factors; D036341:Intercellular Signaling Peptides and Proteins; D008222:Lymphokines; C000608036:PGF protein, human; C000608037:Pgf protein, mouse; D011257:Pregnancy Proteins; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D000072483:Placenta Growth Factor; D040281:Vascular Endothelial Growth Factor Receptor-1; D010100:Oxygen